Concepedia

Christopher Major

CM

12

Publications

1.1K

Citations

11

H-Index

1992

Active since

Affiliations

University of Pennsylvania(Current)

National Cancer Institute

National Institutes of Health

Janssen (United States)

Christopher Major is an author at University of Pennsylvania specializing in medicine, dermatology, and radiation oncology.

Top concepts

Publications per year

1992–2021

12

Publications

12

SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7

Stacey DaCosta Byfield, Christopher Major, Nicholas J. Laping et al. · Molecular Pharmacology · 2004 · 412 citations

Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation

Kathleen C. Flanders, Catherine D. Sullivan, Makiko Fujii et al. · American Journal Of Pathology · 2002 · 280 citations · Full text

, , +6

Interference with Transforming Growth Factor-β/ Smad3 Signaling Results in Accelerated Healing of Wounds in Previously Irradiated Skin

Kathleen C. Flanders, Christopher Major, Alidad Arabshahi et al. · American Journal Of Pathology · 2003 · 165 citations · Full text

, , +12

Diacylglycerol Hydrolysis to Arachidonic Acid Is Necessary for Insulin Secretion from Isolated Pancreatic Islets: Sequential Actions of Diacylglycerol and Monoacylglycerol Lipases

Robert J. Konrad, Christopher Major, Bryan A. Wolf · Biochemistry · 1994 · 87 citations

Inhibition of phospholipase A2 and insulin secretion in pancreatic islets

Robert J. Konrad, Y. Camille Jolly, Christopher Major et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1992 · 55 citations

, , +10

Rows per page

1–5 of 12